La gestione del paziente HBsAg positivo, HCV positivo e HIV positivo in dialisi

Translated title of the contribution: The management of dialysis patients seropositive for HBsAg, anti-HCV, or anti-HIV antibodies

Research output: Contribution to journalArticle

Abstract

Infections by hepatitis B or hepatitis C virus are still common among patients on maintenance dialysis in Western countries. The natural history of HBV and HCV in the dialysis population remains unclear; however, there is good evidence showing an adverse impact of an anti-HCV seropositive status on survival in dialysis patients. A recent meta-analysis of observational studies (n=7, 11,589 unique patients) reported that anti-HCV-positive patients on dialysis had a higher mortality rate than those who were anti-HCV negative (adjusted hazard ratio=1.35, 95% confidence interval, 1.13; 1.59, p

Original languageItalian
Pages (from-to)S78-S84
JournalGiornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Volume29
Publication statusPublished - Sep 1 2012

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this